期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Frontiers in Molecular Neuroscience LetPub Score 7.2
50 ratings
Rate
Reputation 8.3 Influence 6.3 Speed 7.1 | ||||||||||||||||||||
期刊簡稱 | FRONT MOL NEUROSCI | ||||||||||||||||||||
ISSN | 1662-5099 | ||||||||||||||||||||
h-index | 46 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 2.90%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://journal.frontiersin.org/journal/molecular-neuroscience | ||||||||||||||||||||
在線稿件提交 | http://www.frontiersin.org/submission/submissioninfo.aspx | ||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||
出版商 | Frontiers Media S.A. | ||||||||||||||||||||
主題領域 | NEUROSCIENCES | ||||||||||||||||||||
出版國/地區 | SWITZERLAND | ||||||||||||||||||||
發行頻率 | |||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||
每年文章數 | 469每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 99.80% | ||||||||||||||||||||
OA Related Info | APC: Yes( USD3295; ) APC waiver:Check Notes Other charges: No Keywords: neurochemistry、molecular neurosciences、neurotransmitters、rna、molecular pathways Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1662-5099%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 14 Weeks | ||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[Frontiers in Molecular Neuroscience] 的評論 | 撰寫評論 |
作者: Ivan Saroyan 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-08 11:22:46 評論於 3200+ USD(0) 讚! | Ivan Saroyan |
作者: 云来澄邈 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-28 13:30:35 評論於 How much is the layout fee?(0) 讚! | 云来澄邈 |
作者: 云来澄邈 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-28 09:26:46 評論於 How much is the advertising fee?(0) 讚! | 云来澄邈 |
作者: Ivan Saroyan 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-18 13:06:24 評論於 Review speed: 1.0 | Submission hit rate: 75.0 Focus research areas: Pain; Microbiome; Molecular Mechanisms Sharing experience: The efficiency of the magazine is still quite high. The editor found 2 reviewers, one for minor revisions and one for major revisions. They raised questions about supplementary experiments and gave 2 weeks to revise + respond to the reviewers' comments. No additional experiments were conducted, only responses to the comments of the two reviewers. Both reviewers directly endorsed the revisions. Overall, most of the reviewers' comments were quite balanced. The only downside is that the publication fee is too expensive. Only the raw sequencing data was submitted as required by the journal, and the editorial department did not request the raw data from molecular experiments (WB, IF, qPCR, etc.). Timeline reference for each stage: May 30, 2023 Article accepted for publication. May 29, 2023 Review of Review Editor 2 (major revisions) finalized. May 25, 2023 Review of Review Editor 1 (minor revisions) finalized. May 25, 2023 Submitting Author posted new comments and re-submitted manuscript. May 12, 2023 Interactive review forum activated. April 18, 2023 Submitting Author submitted manuscript(0) 讚! | Ivan Saroyan |
作者: Ivan Saroyan 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-15 09:45:36 評論於 Review speed: 1.0 | Submission acceptance rate: 75.0 Focus research areas: Pain; Molecular mechanisms; Gut microbiota Sharing experience: The page fee is too expensive(0) 讚! | Ivan Saroyan |
作者: 北海喜英 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-29 19:03:13 評論於 Do you need all the bands, or just the ones mentioned in the paper?(0) 讚! | 北海喜英 |
作者: 北海喜英 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-29 16:37:21 評論於 If the journal requires WB original bands, should all bands from the statistical data be provided, or only the representative bands that appear in the paper?(0) 讚! | 北海喜英 |
作者: 幽香苗苗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-03 22:49:18 評論於 Is the layout fee $2900?(0) 讚! | 幽香苗苗 |
作者: 明冠宏富 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-20 12:08:07 評論於 Can I ask if the teacher required the original data after initial validation?(0) 讚! | 明冠宏富 |
作者: 桃花映波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-05 22:42:46 評論於 Have you confirmed this with experiments?(0) 讚! | 桃花映波 |
作者: 长安安白 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-05 14:44:40 評論於 Do you have a title of the article? I want to learn about it(0) 讚! | 长安安白 |
作者: 碧桃幻露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-05 18:15:55 評論於 Submitted a bioinformatics article, reviewed for 2 months, accepted in about 3 months, Frontiers is still a relatively good choice for submission(0) 讚! | 碧桃幻露 |
作者: 润津 領域: 生物学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-04-21 16:12:26 評論於 24 Mar 2022 accepted 15 Mar 2022 Review Editor 2 finalized. 07 Mar 2022 Re-submitted manuscript. 06 Mar 2022 Review Editor 1 finalized. 05 Mar 2022 You posted new comments. 01 Mar 2022 Editor 2 posted new comments. 28 Feb 2022 Re-submitted manuscript. 2 Feb 2022 Interactive review forum activated. 25 Jan 2022 Corresponding Author declined transfer. 14 Jan 2022 Corresponding Author submitted manuscript. Translation: 24 Mar 2022 - accepted 15 Mar 2022 - Review Editor 2 finalized. 07 Mar 2022 - Re-submitted manuscript. 06 Mar 2022 - Review Editor 1 finalized. 05 Mar 2022 - You posted new comments. 01 Mar 2022 - Editor 2 posted new comments. 28 Feb 2022 - Re-submitted manuscript. 2 Feb 2022 - Interactive review forum activated. 25 Jan 2022 - Corresponding Author declined transfer. 14 Jan 2022 - Corresponding Author submitted manuscript.(1) 讚! | 润津 |
作者: 一阳一瑾 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-23 13:35:43 評論於 What happened later?(0) 讚! | 一阳一瑾 |
作者: 一阳一瑾 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-23 10:11:06 評論於 What happened next?(0) 讚! | 一阳一瑾 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:23:24 評論於 With the increasing specialization of disciplines, it has become increasingly difficult for journals to find appropriate peer reviewers. Therefore, requesting authors to recommend reviewers is a mutually beneficial practice: journals can find suitable reviewers and save time in searching for appropriate candidates, while authors can provide support through their own networks and recommend scholars who are best able to understand the submitted paper(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 08:09:15 評論於 Most journals require submissions in Word format, but there are also some that require PDF format(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 21:24:40 評論於 What is a recommended reviewer/expert/peer?(0) 讚! | 平原文波 |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 16:43:21 評論於 Should I upload the article in Word or PDF format?(0) 讚! | 修然小公主 |
作者: 上清琳溪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-14 17:36:31 評論於 Is this prescription for individual traditional Chinese medicine ingredients?(0) 讚! | 上清琳溪 |
作者: 上清琳溪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-14 15:35:10 評論於 Are the requirements strict for WB bands? Do we need full membrane?(0) 讚! | 上清琳溪 |
作者: 千花君博 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-29 19:24:00 評論於 Check the data type. For example, if the data can be uploaded to a genetic database, you can provide the number directly in the later stage(0) 讚! | 千花君博 |
作者: 一只付安呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-17 14:19:17 評論於 Hello, may I ask if all original data needs to be provided directly when submitting a contribution?(0) 讚! | 一只付安呀 |
作者: 千花君博 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-17 11:52:56 評論於 You will receive a response within two weeks at the latest, please wait(0) 讚! | 千花君博 |
作者: 西风寒烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-08 22:35:01 評論於 I just submitted my application on November 6th and it is currently in the preliminary review stage. How long does it usually take to move to the next stage?(0) 讚! | 西风寒烟 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us